Location History:
- Granta Park, GB (2012)
- Cambridge, GB (2016 - 2017)
Company Filing History:
3 out of 541 
1 out of 80 Years Active: 2012-2017
Title: Ruth Franks: Innovator in Neuropathic Pain Treatment
Introduction
Ruth Franks is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of medical science, particularly in the treatment of neuropathic pain. With a total of 3 patents to her name, her work focuses on innovative methods that address various NGF-related disorders.
Latest Patents
Ruth Franks' latest patents include groundbreaking methods of treating neuropathic pain using specific binding members for Nerve Growth Factor (NGF). These patents detail the development of anti-NGF antibody molecules, especially human antibody molecules that neutralize NGF activity. Her work also encompasses methods for utilizing these anti-NGF antibody molecules in the diagnosis and treatment of a range of NGF-related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis, and cancer.
Career Highlights
Throughout her career, Ruth has worked with notable companies such as Medimmune Limited and Elan Pharma International Limited. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in medical treatments.
Collaborations
Ruth has collaborated with esteemed colleagues, including Andrew Grier Buchanan and Albert George Thom. These partnerships have further enriched her research and development efforts in the field of neuropathic pain treatment.
Conclusion
Ruth Franks stands out as an innovative inventor whose work has the potential to transform the treatment of neuropathic pain and related disorders. Her contributions to medical science are invaluable and continue to inspire future advancements in the field.